抗抑郁药物药理疗的进展:第三阶段证据和临床前景
Alessandro Cuomo1, Mario Pinzi1, Andrea Fagiolini1
1Division of Psychiatry, Department of Molecular Medicine, University of Siena School of Medicine, Siena, Italy.
Expert opinion on pharmacotherapy
|February 17, 2026
概括
较新的抗抑郁药对主要抑郁障碍 (MDD) 提供了更好的疗效,但在临床整合方面面临挑战. 对个性化抑郁症管理需要进一步的研究和指导方针协调.
科学领域:
- 精神病学和药理学 精神病学和药理学
- 神经科学是一个神经科学.
- 临床治疗学 临床治疗学
背景情况:
- 重度抑郁症 (MDD) 是全球严重的健康负担,许多患者对传统抗抑郁药物反应不佳.
- 目前治疗的局限性包括不充分的反应,部分缓解和治疗耐药性,需要新的治疗策略.
研究的目的:
- 审查抗抑郁药物治疗当前的挑战.
- 为了检查不同抑郁状况中新型抗抑郁药物的第三阶段临床证据.
- 评估这些新型治疗方法在国际临床指南中的整合.
主要方法:
- 在PubMed,Embase,Scopus和ClinicalTrials.gov.gov进行了全面的文献搜索.
- 该搜索涵盖了2000年1月至2025年6月的研究.
- 对特定药物的疗效,安全性和复发预防的数据进行了分析.
主要成果:
- 像布雷克萨诺龙,鼻腔以斯基坦胺,德克斯特罗米多芬-布普罗和伏尔托克塞丁这样的较新的药物显示出有前途.
- 还讨论了基于新陈代谢的干预措施,如葡萄糖样-1受体激活剂 (GLP-1RA).
- 关于它们在临床指南中的位置,发现了不一致性和缺乏正式建议.
结论:
- 较新的抗抑郁药提供了超越传统治疗的潜在益处,包括快速缓解症状和认知/代谢优势.
- 有限的指导方针整合,不足的长期数据和实施障碍阻碍了广泛的临床采用.
- 制定更清晰的测序策略和协调的建议对于个性化的抑郁症管理至关重要.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
974
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
974
01:25Antidepressant Drugs: Overview
1.7K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.7K
01:11Clinical Trials: Overview
5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.7K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.7K
01:28Drug Therapy
315
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
315
01:26Drug Administration and Therapy Phases: Overview
1.5K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.5K